Search research articles
Contact Us
Filters
Showing results (331-340 of 444) with videos related to
Page
of 45
Sort By:
The Lancet. Oncology
|
November 25, 2017
Cetuximab plus carboplatin and paclitaxel with or without bevacizumab versus carboplatin and paclitaxel with or without bevacizumab in advanced NSCLC (SWOG S0819): a randomised, phase 3 study
Roy S Herbst, Mary W Redman, Edward S Kim, et al.
Cell Stem Cell
|
June 19, 2018
AMPK/FIS1-Mediated Mitophagy Is Required for Self-Renewal of Human AML Stem Cells
Shanshan Pei, Mohammad Minhajuddin, Biniam Adane, et al.
Nature Medicine
|
October 17, 2017
Targeting glioma stem cells through combined BMI1 and EZH2 inhibition
Xun Jin, Leo J Y Kim, Qiulian Wu, et al.
Prostate Cancer and Prostatic Diseases
|
March 26, 2021
Comprehensive Lifestyle Improvement Program for Prostate Cancer (CLIPP) is associated with improvement in weight and components of metabolic syndrome in men exposed to androgen deprivation therapy for prostate cancer
A M Algotar, C H Hsu, H-H Chow, et al.
Cancer
|
December 9, 2022
Baseline extracellular vesicle TGF-β is a predictive biomarker for response to immune checkpoint inhibitors and survival in non-small cell lung cancer
Diego de Miguel-Perez, Alessandro Russo, Muthukumar Gunasekaran, et al.
Cancer Discovery
|
August 29, 2019
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock
Zhen Dong, Guoxin Zhang, Meng Qu, et al.
The ISME Journal
|
March 30, 2021
The temperature sensitivity of soil: microbial biodiversity, growth, and carbon mineralization
Chao Wang, Ember M Morrissey, Rebecca L Mau, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 30, 2025
B7-H3 CAR T Cells Are Effective against Ependymomas but Limited by Tumor Size and Immune Response
Sanya Mehta, Siri Ippagunta, Srinidhi Varadharajan, et al.
Clinical Lung Cancer
|
November 22, 2020
A Phase II Study of Telisotuzumab Vedotin in Patients With c-MET-positive Stage IV or Recurrent Squamous Cell Lung Cancer (LUNG-MAP Sub-study S1400K, NCT03574753)
Saiama N Waqar, Mary W Redman, Susanne M Arnold, et al.
Science (New York, N.Y.)
|
November 18, 2006
The impact of boreal forest fire on climate warming
J T Randerson, H Liu, M G Flanner, et al.
Page
of 45
Search research articles
Search
Showing results (331-340 of 444) with videos related to
Sort By:
Page
of 45
The Lancet. Oncology
|
November 25, 2017
Cetuximab plus carboplatin and paclitaxel with or without bevacizumab versus carboplatin and paclitaxel with or without bevacizumab in advanced NSCLC (SWOG S0819): a randomised, phase 3 study
Roy S Herbst, Mary W Redman, Edward S Kim, et al.
Cell Stem Cell
|
June 19, 2018
AMPK/FIS1-Mediated Mitophagy Is Required for Self-Renewal of Human AML Stem Cells
Shanshan Pei, Mohammad Minhajuddin, Biniam Adane, et al.
Nature Medicine
|
October 17, 2017
Targeting glioma stem cells through combined BMI1 and EZH2 inhibition
Xun Jin, Leo J Y Kim, Qiulian Wu, et al.
Prostate Cancer and Prostatic Diseases
|
March 26, 2021
Comprehensive Lifestyle Improvement Program for Prostate Cancer (CLIPP) is associated with improvement in weight and components of metabolic syndrome in men exposed to androgen deprivation therapy for prostate cancer
A M Algotar, C H Hsu, H-H Chow, et al.
Cancer
|
December 9, 2022
Baseline extracellular vesicle TGF-β is a predictive biomarker for response to immune checkpoint inhibitors and survival in non-small cell lung cancer
Diego de Miguel-Perez, Alessandro Russo, Muthukumar Gunasekaran, et al.
Cancer Discovery
|
August 29, 2019
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock
Zhen Dong, Guoxin Zhang, Meng Qu, et al.
The ISME Journal
|
March 30, 2021
The temperature sensitivity of soil: microbial biodiversity, growth, and carbon mineralization
Chao Wang, Ember M Morrissey, Rebecca L Mau, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 30, 2025
B7-H3 CAR T Cells Are Effective against Ependymomas but Limited by Tumor Size and Immune Response
Sanya Mehta, Siri Ippagunta, Srinidhi Varadharajan, et al.
Clinical Lung Cancer
|
November 22, 2020
A Phase II Study of Telisotuzumab Vedotin in Patients With c-MET-positive Stage IV or Recurrent Squamous Cell Lung Cancer (LUNG-MAP Sub-study S1400K, NCT03574753)
Saiama N Waqar, Mary W Redman, Susanne M Arnold, et al.
Science (New York, N.Y.)
|
November 18, 2006
The impact of boreal forest fire on climate warming
J T Randerson, H Liu, M G Flanner, et al.
Page
of 45